SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001410578-19-001324
Filing Date
2019-09-19
Accepted
2019-09-19 16:30:37
Documents
12
Period of Report
2019-09-18
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tv529754_8k.htm   iXBRL 8-K 21690
  Complete submission text file 0001410578-19-001324.txt   192207

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA pcrx-20190918.xsd EX-101.SCH 3181
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE pcrx-20190918_lab.xml EX-101.LAB 33476
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE pcrx-20190918_pre.xml EX-101.PRE 21955
5 EXTRACTED XBRL INSTANCE DOCUMENT tv529754_8k_htm.xml XML 3606
Mailing Address 5 SYLVAN WAY SUITE 300 PARSIPPANY NJ 07054
Business Address 5 SYLVAN WAY SUITE 300 PARSIPPANY NJ 07054 973-254-3560
Pacira BioSciences, Inc. (Filer) CIK: 0001396814 (see all company filings)

IRS No.: 510619477 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35060 | Film No.: 191102037
SIC: 2834 Pharmaceutical Preparations